Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort.
Fine SR, Bazzi LA, Callear AP, Petrie JG, Malosh RE, Foster-Tucker JE, Smith M, Ibiebele J, McDermott A, Rolfes MA, Monto AS, Martin ET. Fine SR, et al. Among authors: monto as. Influenza Other Respir Viruses. 2023 Mar 1;17(3):e13106. doi: 10.1111/irv.13106. eCollection 2023 Mar. Influenza Other Respir Viruses. 2023. PMID: 36875204 Free PMC article.
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
WHO Writing Group; Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W. WHO Writing Group, et al. Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8. Influenza Other Respir Viruses. 2012. PMID: 21819547 Free PMC article.
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
WHO Writing Group; Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W. WHO Writing Group, et al. Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2(Suppl 2):52-53. doi: 10.1111/irv.12081. Influenza Other Respir Viruses. 2013. PMID: 24034484 Free PMC article. No abstract available.
Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, Silveira FP, Talbot HK, Zimmerman R, Alyanak E, Strickland C, Spencer S, Fry AM; HAIVEN Study Investigators. Ferdinands JM, et al. Among authors: monto as. J Infect Dis. 2019 Sep 13;220(8):1265-1275. doi: 10.1093/infdis/jiy723. J Infect Dis. 2019. PMID: 30561689 Free PMC article.
Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017.
Doyle JD, Beacham L, Martin ET, Talbot HK, Monto A, Gaglani M, Middleton DB, Silveira FP, Zimmerman RK, Alyanak E, Smith ER, Flannery BL, Rolfes M, Ferdinands JM. Doyle JD, et al. Clin Infect Dis. 2021 Mar 15;72(6):995-1003. doi: 10.1093/cid/ciaa160. Clin Infect Dis. 2021. PMID: 32067049 Free PMC article.
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
Tenforde MW, Patel MM, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CT, Busse L, Lohuis CCT, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Gershengorn HB, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Stephenson M, Schrag SJ, Kobayashi M, Verani JR, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Tenforde MW, et al. Among authors: monto as. medRxiv [Preprint]. 2021 Jul 8:2021.07.08.21259776. doi: 10.1101/2021.07.08.21259776. medRxiv. 2021. Update in: Clin Infect Dis. 2022 May 3;74(9):1515-1524. doi: 10.1093/cid/ciab687 PMID: 34268515 Free PMC article. Updated. Preprint.
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
Thompson MG, Soto G, Peretz A, Newes-Adeyi G, Yoo YM, Hirsch A, Katz MA, Tinoco Y, Shemer Avni Y, Ticona E, Malosh R, Martin E, Matos E, Reynolds S, Wesley M, Ferdinands J, Cheung A, Levine M, Bravo E, Arriola CS, Ester Castillo M, Carlos Castro J, Dawood F, Greenberg D, Manuel Neyra Quijandría J, Azziz-Baumgartner E, Monto A, Balicer RD. Thompson MG, et al. Vaccine. 2021 Nov 16;39(47):6956-6967. doi: 10.1016/j.vaccine.2021.07.077. Epub 2021 Sep 9. Vaccine. 2021. PMID: 34509322
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
Adams K, Rhoads JP, Surie D, Gaglani M, Ginde AA, McNeal T, Talbot HK, Casey JD, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Frosch AE, Exline MC, Mohamed A, Johnson NJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Lauring AS, Khan A, Busse LW, Duggal A, Wilson JG, Chang SY, Mallow C, Kwon JH, Chappell JD, Halasa N, Grijalva CG, Lindsell CJ, Lester SN, Thornburg NJ, Park S, McMorrow ML, Patel MM, Tenforde MW, Self WH; Influenza and other Viruses in the AcutelY ill (IVY) Network. Adams K, et al. BMJ. 2022 Oct 11;379:e072065. doi: 10.1136/bmj-2022-072065. BMJ. 2022. PMID: 36220174 Free PMC article.
374 results